Tolperisone Hydrochloride

盐酸甲哌酮

Report date: 2023/02/08 16:34:12
NME

Base Information

Drug NameTolperisone Hydrochloride
Drug Alias NametolperisonatolperisonumViveoMydocalmAV-650 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersVoltage-gated calcium channel blockers
TargetsSodium channel alpha subunitVoltage-gated calcium channel
Therapy Area/IndicationsSprains and StrainsLow Back PainBack Pain +[12] 
Global Approved IndicationsEndarteritisArteriosclerosisStroke +[6] 
Approved Indications in ChinaEndarteritisArteriosclerosisStroke +[6] 
Original Approved Country/TerritoryHong Kong
Original Approved Date1985/09/19
Country/TerritoryCanadaUnited StatesHungary +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesNeurana Pharmaceuticals IncMeditop Gyógyszeripari KftSemmelweis University +[4] 
Inactive CompaniesAvigen Inc
Active IndicationsSprains and StrainsLow Back PainBack Pain +[11] 
Inactive IndicationsMuscle Cramp

Other Information

ATC CodeM02AX06M03BX04
Related LinksWikipediaKEGG